Inventor
STONE EVERETT
US33 patents
⚠️ This page may combine multiple inventors who share the name “STONE EVERETT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV TEXAS
22 patentsUS9808486B2Nov 7, 2017
Administration of kynurenine depleting enzymes for tumor therapy
UNIV TEXAS17 citations92
US9481877B2Nov 1, 2016
Engineered primate L-methioninase for therapeutic purposes
UNIV TEXAS14 citations92
US10772913B2Sep 15, 2020
Administration of kynurenine depleting enzymes for tumor therapy
UNIV TEXAS5 citations84
US10363311B2Jul 30, 2019
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
UNIV TEXAS4 citations84
US10233438B2Mar 19, 2019
Engineered primate L-methioninase for therapeutic purposes
UNIV TEXAS6 citations83
US9975959B2May 22, 2018
Administration of kynurenine depleting enzymes for tumor therapy
UNIV TEXAS8 citations83
US9624484B2Apr 18, 2017
Engineered primate L-methioninase for therapeutic purposes
UNIV TEXAS11 citations83
US11534463B2Dec 27, 2022
Nucleic acids encoding kynurenine depleting enzymes
UNIV TEXAS1 citations73
US10716856B2Jul 21, 2020
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
UNIV TEXAS2 citations73
US11168142B2Nov 9, 2021
Administration of kynurenine depleting enzymes for tumor therapy
UNIV TEXAS5 citations72
US10724026B2Jul 28, 2020
Engineered primate L-methioninase for therapeutic purposes
UNIV TEXAS2 citations72
US11648272B2May 16, 2023
Human kynureninase enzymes and uses thereof
UNIV TEXAS2 citations70
US11118167B2Sep 14, 2021
Enzyme-mediated depletion of adenosine and/or methylthioadenosine
UNIV TEXAS3 citations64
US12036269B2Jul 16, 2024
Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
UNIV TEXAS0 citations62
US11591579B2Feb 28, 2023
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
UNIV TEXAS0 citations62
US11426464B2Aug 30, 2022
Engineered primate cystine/cysteine degrading enzymes as antineogenic agents
UNIV TEXAS0 citations62
US11396647B2Jul 26, 2022
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
UNIV TEXAS0 citations62
US11033612B2Jun 15, 2021
Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria
UNIV TEXAS0 citations62
US11542486B2Jan 3, 2023
Human kynureninase enzyme variants having improved pharmacological properties
UNIV TEXAS1 citations61
US12163168B2Dec 10, 2024
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
UNIV TEXAS0 citations59
US12144828B2Nov 19, 2024
Human Kynureninase enzymes and uses thereof
UNIV TEXAS0 citations59
US10865403B2Dec 15, 2020
Engineered primate cystine/cysteine degrading enzymes for therapeutic uses
UNIV TEXAS1 citations56
AEMASE INC
4 patentsUS9909163B2Mar 6, 2018
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
AEMASE INC11 citations92
US9279119B2Mar 8, 2016
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
AEMASE INC11 citations92
US10526638B2Jan 7, 2020
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
AEMASE INC3 citations72
US11584949B2Feb 21, 2023
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
AEMASE INC0 citations62
GEORGIOU GEORGE
3 patentsUS8709407B2Apr 29, 2014
Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof
GEORGIOU GEORGE17 citations92
US8440184B2May 14, 2013
Compositions of engineered human arginases and methods for treating cancer
GEORGIOU GEORGE19 citations92
US8679479B2Mar 25, 2014
Methods for purifying pegylated arginase
GEORGIOU GEORGE11 citations84
AERASE INC
3 patentsUS10098933B2Oct 16, 2018
Compositions of engineered human arginases and methods for treating cancer
AERASE INC4 citations83
US9050340B2Jun 9, 2015
Compositions of engineered human arginases and methods for treating cancer
AERASE INC7 citations83
USRE46423EJun 6, 2017
Compositions of engineered human arginases and methods for treating cancer
AERASE INC2 citations72